メチル構成ダイナミクスによるKRASのエフェクターとアロステリックロブ間のクロストークに関する洞察
Fa-An Chao1, Srisathiyanarayanan Dharmaiah1, Troy Taylor1
1NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, Maryland 21701, United States.
Journal of the American Chemical Society
|February 25, 2022
まとめ
研究者は,がんの変異を理解するために,NMRを用いてKRASタンパク質の動態を研究した. カスタマイズされたNMR技術は,RAF1のような下流エフェクタとの相互作用に影響を与える同期した動きを明らかにし,変異体の結合親和性を予測するのに役立ちます.
科学分野:
- バイオ物理学
- 分子生物学
- 癌 研究
背景:
- KRASはがんで最も頻繁に変異したRASタンパク質で,米国のがん患者の約20%に影響します.
- RASタンパク質の構造とダイナミクスは治療開発に不可欠ですが,複雑な構成ダイナミクスは研究に困難です.
- 31P NMRを含む以前の研究は,主要な状態を特定したが,効果因子の相互作用に影響を与える微妙な動態を見逃した.
研究 の 目的:
- RASタンパク質のミリ秒からマイクロ秒までの構成ダイナミクスを体系的に調べる.
- これらのダイナミクスが下流エフェクタ,特にKRASとRAF1との相互作用を調節する方法を調査する.
- KRAS変異体の変化した結合親和性を予測する枠組みを開発する.
主な方法:
- 確立されたカスタマイズされた核磁気共鳴 (NMR) のリラックス分散技術.
- これらの技術を効率的かつ体系的に ms-micro 形状のダイナミクスに適用した.
- KRASとRAF1のRas結合領域の相互作用を調査した.
主要な成果:
- KRASでは,効果器とアロステリックロブを結ぶ異なる同期運動が観察されました.
- RAF1との相互作用を制御するKRASの構成ダイナミクスの重要な役割を実証した.
- KRAS変異体の変化した結合親和性を説明し,予測するためのダイナミックな基礎を提供した.
結論:
- カスタマイズされたNMRリラクゼーション分散は,KRAS構造動態の研究に有効です.
- コンフォーマーションダイナミクスは,KRASエフェクター相互作用と突然変異の結合アフィニティの重要な決定因子である.
- この研究は,KRAS媒介のシグナル伝達と潜在的な治療戦略に関する新しい洞察を提供します.
関連する概念動画
Cooperative Allosteric Transitions
2.6K
2.6K
Allosteric Regulation
60.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
60.2K
Ligand Binding and Linkage
5.0K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.0K
MAPK Signaling Cascades
6.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
Allosteric Proteins-ATCase
6.0K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.0K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K


